Project Number PTC REG-20-653582 Agency/Funding Organization Alzheimer's Association Funding Year 2020 View Full Project Details for Biomarker & Neural System Effects of Calcineurin Inhibition with Tacrolimus Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator ARNOLD, STEVEN E. Principal Investigator First Name STEVEN Principal Investigator Last Name ARNOLD Awardee Organization Massachusetts General Hospital (The General Hospital Corp.) Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2020: PTC RFA FY Overall Cost $749,999 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Murtishaw, Andrew asmurtishaw@alz.org
